{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:30:07Z","timestamp":1794267007709,"version":"4.9.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-21606-1","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:06:39Z","timestamp":1761663999000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Nanotechnology Meets superbugs: biocompatible polymeric nanoparticles combat MDR Klebsiella pneumoniae via gene suppression and biofilm Inhibition"],"prefix":"10.1038","volume":"15","author":[{"given":"Farnaz Afshar","family":"Ebrahimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Siasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Yazdian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Ashrafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"key":"21606_CR1","unstructured":"World Health Organization. WHO launches first ever global report on infection prevention and control [Internet]. World Health Organisation. (2022). Available from: https:\/\/www.who.int\/news\/item\/06-05-2022-who-launches-first-ever-global-report-on-infection-prevention-and-control"},{"key":"21606_CR2","doi-asserted-by":"publisher","first-page":"151594","DOI":"10.1016\/j.ijmm.2023.151594","volume":"314","author":"P Gastmeier","year":"2024","unstructured":"Gastmeier, P., Kola, A., Schwab, F., Geffers, C. & Michael Behnke, and Etiology of nosocomial infections in intensive care patients in German hospitals: an analysis of trends between 2008 and 2022. Int. J. Med. Microbiol. 314, 151594 (2024).","journal-title":"Int. J. Med. Microbiol."},{"issue":"7","key":"21606_CR3","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.molmed.2015.03.005","volume":"21","author":"S Lax","year":"2015","unstructured":"Lax, S., Jack, A. & Gilbert Hospital-associated microbiota and implications for nosocomial infections. Trends Mol. Med. 21 (7), 427\u2013432 (2015).","journal-title":"Trends Mol. Med."},{"issue":"8","key":"21606_CR4","doi-asserted-by":"publisher","first-page":"e10060","DOI":"10.7759\/cureus.10060","volume":"12","author":"A Al Bshabshe","year":"2020","unstructured":"Al Bshabshe, A. et al. Rising Klebsiella pneumoniae infections and its expanding drug resistance in the intensive care unit of a tertiary healthcare Hospital, Saudi Arabia. Cureus 12 (8), e10060. https:\/\/doi.org\/10.7759\/cureus.10060 (2020). PMID: 32999783; PMCID: PMC7520404.","journal-title":"Cureus"},{"key":"21606_CR5","doi-asserted-by":"publisher","unstructured":"Guerra, M. E. S. et al. Klebsiella pneumoniae Biofilms and Their Role in Disease Pathogenesis [published correction appears in Front Cell Infect Microbiol. ;15:1564010. (2025). https:\/\/doi.org\/10.3389\/fcimb2025.1564010.]. Front Cell Infect Microbiol. 2022;12:877995. Published 2022 May 11. doi:10.3389\/fcimb.2022.877995.","DOI":"10.3389\/fcimb"},{"issue":"2","key":"21606_CR6","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3390\/biology13020078","volume":"13","author":"R Abbas","year":"2024","unstructured":"Abbas, R. et al. General overview of Klebsiella pneumonia: epidemiology and the role of siderophores in its pathogenicity. Biology (Basel). 13 (2), 78. https:\/\/doi.org\/10.3390\/biology13020078 (2024). PMID: 38392297; PMCID: PMC10886558.","journal-title":"Biology (Basel)"},{"key":"21606_CR7","doi-asserted-by":"publisher","first-page":"155753","DOI":"10.1016\/j.cej.2024.155753","volume":"498","author":"W Zhong","year":"2024","unstructured":"Zhong, W. et al. Enhancing safe and effective treatment of carbapenem-resistant Klebsiella pneumoniae with polymyxin B-loaded dendritic nanoparticles. Chem. Eng. J. 498, 155753\u2013155753. https:\/\/doi.org\/10.1016\/j.cej.2024.155753 (2024).","journal-title":"Chem. Eng. J."},{"issue":"5","key":"21606_CR8","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1586\/14787210.2014.902306","volume":"12","author":"AY Guh","year":"2014","unstructured":"Guh, A. Y., Limbago, B. M. & Kallen, A. J. Epidemiology and prevention of carbapenem-resistant Enterobacteriaceae in the united States. Expert Rev. Anti Infect. Ther. 12 (5), 565\u2013580. https:\/\/doi.org\/10.1586\/14787210.2014.902306 (2014).","journal-title":"Expert Rev. Anti Infect. Ther."},{"issue":"1","key":"21606_CR9","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.3892\/etm.2017.5485","volume":"15","author":"Y Ye","year":"2018","unstructured":"Ye, Y. et al. Mechanism for carbapenem resistance of clinical Enterobacteriaceae isolates. Exp. Ther. Med. 15 (1), 1143\u20131149. https:\/\/doi.org\/10.3892\/etm.2017.5485 (2018). Epub 2017 Nov 10. PMID: 29399114; PMCID: PMC5772903.","journal-title":"Exp. Ther. Med."},{"key":"21606_CR10","doi-asserted-by":"crossref","unstructured":"Mathers, A. J. et al. Molecular Dissection of an Outbreak of Carbapenem-Resistant Enterobacteriaceae Reveals Intergenus KPC Carbapenemase Transmission through a Promiscuous Plasmid. Bush K, editor. mBio. ;2(6). (2011).","DOI":"10.1128\/mBio.00204-11"},{"key":"21606_CR11","unstructured":"Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, Atlanta & U.S. Department of Health and Human Services. GA: ; 2013. (2013). Available from: https:\/\/www.cdc.gov\/drugresistance\/pdf\/ar-threats-2013-508.pdf"},{"key":"21606_CR12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3390\/amh69020009","volume":"69","author":"A Papanikolopoulou","year":"2024","unstructured":"Papanikolopoulou, A. et al. Carbapenem-Resistant Klebsiella pneumoniae bacteremia: counterbalance between the endemic load and the infection control program in a hospital. Acta Microbiol. Hell. 69, 81\u201392. https:\/\/doi.org\/10.3390\/amh69020009 (2024).","journal-title":"Acta Microbiol. Hell"},{"issue":"2","key":"21606_CR13","doi-asserted-by":"publisher","first-page":"ofad649","DOI":"10.1093\/ofid\/ofad649","volume":"11","author":"XC Lin","year":"2023","unstructured":"Lin, X. C., Li, C. L., Zhang, S. Y., Yang, X. F. & Jiang, M. The global and regional prevalence of Hospital-Acquired Carbapenem-Resistant Klebsiella pneumoniae infection: A systematic review and Meta-analysis. Open. Forum Infect. Dis. 11 (2), ofad649. https:\/\/doi.org\/10.1093\/ofid\/ofad649 (2023). Published 2023 Dec 19.","journal-title":"Open. Forum Infect. Dis."},{"key":"21606_CR14","doi-asserted-by":"publisher","unstructured":"Jafari Sales, A., Soleimani, H. & Moradi, L. Antibiotic resistance pattern in Klebsiella pneumoniae strains isolated from children with urinary tract infections from Tabriz hospitals. 4. 38\u201345. (2020). https:\/\/doi.org\/10.22034\/HBB.2020.03","DOI":"10.22034\/HBB.2020.03"},{"key":"21606_CR15","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.addr.2021.04.005","volume":"174","author":"S Birk","year":"2021","unstructured":"Birk, S. & Egebro Anja Boisen, and line Hagner Nielsen. Polymeric nano-and microparticulate drug delivery systems for treatment of biofilms. Adv. Drug Deliv. Rev. 174, 30\u201352 (2021).","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"21606_CR16","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1039\/C7CS00748E","volume":"48","author":"A Gupta","year":"2019","unstructured":"Gupta, A. et al. Rotello. Combatting antibiotic-resistant bacteria using nanomaterials. Chem. Soc. Rev. 48 (2), 415\u2013427 (2019).","journal-title":"Chem. Soc. Rev."},{"issue":"7","key":"21606_CR17","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1111\/j.1462-5822.2009.01323.x","volume":"11","author":"Hall-Stoodley","year":"2009","unstructured":"Hall-Stoodley Luanne, and Paul Stoodley. Evolving concepts in biofilm infections. Cell. Microbiol. 11 (7), 1034\u20131043 (2009).","journal-title":"Cell. Microbiol."},{"issue":"2","key":"21606_CR18","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1128\/CMR.15.2.167-193.2002","volume":"15","author":"RM Donlan","year":"2002","unstructured":"Donlan, R. M. William Costerton. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15 (2), 167\u2013193 (2002).","journal-title":"Clin. Microbiol. Rev."},{"key":"21606_CR19","doi-asserted-by":"crossref","unstructured":"Mishra, B. et al. and Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery. Nanomedicine: Nanotechnology, biology and medicine 6, no. 1. : 9\u201324. (2010).","DOI":"10.1016\/j.nano.2009.04.008"},{"key":"21606_CR20","doi-asserted-by":"crossref","unstructured":"Patil, J. S., Dhadde, S. B. & Chandakavathe, B. N. Nanostructure drug delivery system is an option to solve antimicrobial drug resistance. Elsevier eBooks ;165\u2013197. (2018).","DOI":"10.1016\/B978-0-12-814031-4.00007-6"},{"key":"21606_CR21","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.3390\/molecules25092090","volume":"25","author":"R Batul","year":"2020","unstructured":"Batul, R., Bhave, M., Mahon, J. & Yu, A. Polydopamine nanosphere with In-Situ loaded gentamicin and its antimicrobial activity. Molecules 25, 2090. https:\/\/doi.org\/10.3390\/molecules25092090 (2020).","journal-title":"Molecules"},{"key":"21606_CR22","doi-asserted-by":"publisher","unstructured":"Patwekar, M. et al. Vancomycin as an Antibacterial Agent Capped with Silver Nanoparticles: An Experimental Potential Analysis. Biomed Res Int. ;2022:3682757. doi: 10.1155\/2022\/3682757. Retraction in: Biomed Res Int. 2024;2024:9784637. (2022). https:\/\/doi.org\/10.1155\/2024\/9784637. PMID: 36046462; PMCID: PMC9420617.","DOI":"10.1155\/2024\/9784637"},{"key":"21606_CR23","doi-asserted-by":"publisher","first-page":"1166790","DOI":"10.3389\/fbioe.2023.1166790","volume":"11","author":"S Gui","year":"2023","unstructured":"Gui, S. et al. A fresh pH-responsive imipenem-loaded nanocarrier against acinetobacter baumannii with a synergetic effect. Front. Bioeng. Biotechnol. 11, 1166790. https:\/\/doi.org\/10.3389\/fbioe.2023.1166790 (2023). PMID: 37113664; PMCID: PMC10128990.","journal-title":"Front. Bioeng. Biotechnol."},{"key":"21606_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-19-1854-4_12","volume-title":"Alternatives To Antibiotics","author":"A Tirkey","year":"2022","unstructured":"Tirkey, A. et al. Polymeric nanoparticles and nanocomposites as antibacterial agents. In Alternatives To Antibiotics (eds Saha, T., Adhikari, D., Tiwary, M. et al.) (Springer, 2022). https:\/\/doi.org\/10.1007\/978-981-19-1854-4_12."},{"key":"21606_CR25","doi-asserted-by":"crossref","unstructured":"Lam, S. J., Edgar, H. H., Wong, C., Boyer & Greg, G. Qiao. Antimicrobial polymeric nanoparticles. Prog. Polym. Sci. 76 2018: 40\u201364 .","DOI":"10.1016\/j.progpolymsci.2017.07.007"},{"key":"21606_CR26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1039\/b509097k","volume":"15","author":"C Sanchez","year":"2005","unstructured":"Sanchez, C., Juli\u00e1n, B., Belleville, P. & Popall, M. Applications of hybrid organic\u2013inorganic nanocomposites. J. Mater. Chem. 15, 35\u201336 (2005).","journal-title":"J. Mater. Chem."},{"key":"21606_CR27","doi-asserted-by":"crossref","unstructured":"Tran, S. & DeGiovanni, P. J. Brandon Piel, and Prakash Rai. Cancer nanomedicine: a review of recent success in drug delivery. Clin. Translational Med. 6 2017: 1\u201321 .","DOI":"10.1186\/s40169-017-0175-0"},{"issue":"2","key":"21606_CR28","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/pj.2014.129","volume":"47","author":"M Tanaka","year":"2015","unstructured":"Tanaka, M. et al. Design of biocompatible and biodegradable polymers based on intermediate water concept. Polym. J. 47 (2), 114\u2013121 (2015).","journal-title":"Polym. J."},{"key":"21606_CR29","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.progpolymsci.2007.05.017","volume":"32","author":"LS Nair","year":"2007","unstructured":"Nair, L. S. & Cato, T. Laurencin. Biodegradable polymers as biomaterials. Prog. Polym. Sci. 32, 8\u20139 (2007).","journal-title":"Prog. Polym. Sci."},{"issue":"2","key":"21606_CR30","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1021\/bm0494702","volume":"6","author":"M Vert","year":"2005","unstructured":"Vert, M. Aliphatic polyesters: great degradable polymers that cannot do everything. Biomacromolecules 6 (2), 538\u2013546 (2005).","journal-title":"Biomacromolecules"},{"issue":"2","key":"21606_CR31","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3390\/antibiotics13020121","volume":"13","author":"P Ioannou","year":"2024","unstructured":"Ioannou, P., Baliou, S. & Samonis, G. Nanotechnology in the diagnosis and treatment of Antibiotic-Resistant infections. Antibiotics 13 (2), 121 (2024).","journal-title":"Antibiotics"},{"issue":"4","key":"21606_CR32","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1080\/10837450.2018.1502317","volume":"24","author":"S Srisang","year":"2019","unstructured":"Srisang, S. & Nasongkla, N. Spray coating of Foley urinary catheter by chlorhexidine-loadedpoly (\u03b5-caprolactone) nanospheres: effect of lyoprotectants, characteristics, and antibacterial activity evaluation. Pharm. Dev. Technol. 24 (4), 402\u2013409 (2019).","journal-title":"Pharm. Dev. Technol."},{"issue":"16","key":"21606_CR33","doi-asserted-by":"publisher","first-page":"4866","DOI":"10.3390\/molecules26164866","volume":"26","author":"A Di Salle","year":"2021","unstructured":"Di Salle, A. et al. Antimicrobial and antibiofilm activity of curcumin-loaded electrospun nanofibers for the prevention of the biofilm-associated infections. Molecules 26 (16), 4866 (2021).","journal-title":"Molecules"},{"key":"21606_CR34","doi-asserted-by":"crossref","unstructured":"Permana, A., Dian, M., Mir, E., Utomo & Ryan, F. Donnelly. Bacterially sensitive nanoparticle-based dissolving microneedles of Doxycycline for enhanced treatment of bacterial biofilm skin infection: A proof of concept study. Int. J. Pharmaceutics: X 2 : 100047. (2020).","DOI":"10.1016\/j.ijpx.2020.100047"},{"issue":"11","key":"21606_CR35","doi-asserted-by":"publisher","first-page":"606","DOI":"10.3390\/pharmaceutics11110606","volume":"11","author":"M Mir","year":"2019","unstructured":"Mir, M. et al. Donnelly, and Asim Ur Rehman. Enhancement in site-specific delivery of carvacrol against methicillin resistant Staphylococcus aureus induced skin infections using enzyme responsive nanoparticles: a proof of concept study. Pharmaceutics 11 (11), 606 (2019).","journal-title":"Pharmaceutics"},{"issue":"3","key":"21606_CR36","doi-asserted-by":"publisher","first-page":"241","DOI":"10.34172\/bi.2023.24252","volume":"13","author":"M Yousefnezhad","year":"2023","unstructured":"Yousefnezhad, M., Davaran, S., Babazadeh, M., Akbarzadeh, A. & Pazoki-Toroudi, H. PCL-based nanoparticles for doxorubicin-ezetimibe co-delivery: A combination therapy for prostate cancer using a drug repurposing strategy. Bioimpacts 13 (3), 241\u2013253. https:\/\/doi.org\/10.34172\/bi.2023.24252 (2023). Epub 2023 Jan 1. PMID: 37431480; PMCID: PMC10329752.","journal-title":"Bioimpacts"},{"issue":"1","key":"21606_CR37","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1186\/s12866-024-03615-8","volume":"24","author":"N Rahmanian","year":"2024","unstructured":"Rahmanian, N., Moulavi, P., Ashrafi, F., Sharifi, A. & Asadi, S. Surface-functionalized UIO-66-NH2 for dual-drug delivery of Vancomycin and Amikacin against Vancomycin-resistant Staphylococcus aureus. BMC Microbiol. 24 (1), 462. https:\/\/doi.org\/10.1186\/s12866-024-03615-8 (2024). Published 2024 Nov 8.","journal-title":"BMC Microbiol."},{"key":"21606_CR38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jgar.2025.01.010","volume":"42","author":"SB Lashaki","year":"2025","unstructured":"Lashaki, S. B., Moulavi, P., Ashrafi, F., Sharifi, A. & Asadi, S. Imipenem\/cilastatin encapsulation in UIO-66-NH2 carrier as a new strategy for combating imipenem-resistant Pseudomonas aeruginosa isolates. J. Glob Antimicrob. Resist. 42, 15\u201327. https:\/\/doi.org\/10.1016\/j.jgar.2025.01.010 (2025).","journal-title":"J. Glob Antimicrob. Resist."},{"key":"21606_CR39","doi-asserted-by":"crossref","unstructured":"Dehbashi, S., Tahmasebi, H., Alikhani, M. Y., Keramat, F. & Mohammad Reza Arabestani. and. Distribution of class B and class A \u03b2-lactamases in clinical strains of Pseudomonas aeruginosa: comparison of phenotypic methods and high-resolution melting analysis (HRMA) assay. Infect. Drug Resist. 2020: 2037\u20132052 .","DOI":"10.2147\/IDR.S255292"},{"issue":"6","key":"21606_CR40","first-page":"1000299","volume":"7","author":"K Ewa","year":"2016","unstructured":"Ewa, K. et al. Rapid detection of NDM, VIM, KPC and IMP carbapenemases by real-time PCR. J. Bacteriol. Parasitol. 7 (6), 1000299 (2016).","journal-title":"J. Bacteriol. Parasitol."},{"issue":"sup1","key":"21606_CR41","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1080\/13102818.2009.10818547","volume":"23","author":"K Petrov","year":"2009","unstructured":"Petrov, K. & Petrova, P. Isolation and molecular identification of Klebsiella pneumoniae strains, producing diols from glycerol. Biotechnol. Biotechnol. Equip. 23 (sup1), 814\u2013817 (2009).","journal-title":"Biotechnol. Biotechnol. Equip."},{"key":"21606_CR42","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ijid.2017.04.007","volume":"59","author":"A Bartolini","year":"2017","unstructured":"Bartolini, A. et al. Prevalence, molecular epidemiology and intra-hospital acquisition of Klebsiella pneumoniae strains producing carbapenemases in an Italian teaching hospital from January 2015 to September 2016. Int. J. Infect. Dis. 59, 103\u2013109 (2017).","journal-title":"Int. J. Infect. Dis."},{"key":"21606_CR43","doi-asserted-by":"publisher","unstructured":"Shrivastava, S. R. B. L., Shrivastava, P. S. & Ramasamy Jegadeesh. World health organization releases global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. Journal of Medical Society 32(1):p 76\u201377, Jan\u2013Apr | (2018). https:\/\/doi.org\/10.4103\/jms.jms_25_17","DOI":"10.4103\/jms.jms_25_17"},{"key":"21606_CR44","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41392-024-01745-z","volume":"9","author":"Y Huang","year":"2024","unstructured":"Huang, Y. et al. Nanotechnology\u2019s frontier in combatting infectious and inflammatory diseases: prevention and treatment. Sig Transduct. Target. Ther. 9, 34. https:\/\/doi.org\/10.1038\/s41392-024-01745-z (2024).","journal-title":"Sig Transduct. Target. Ther."},{"issue":"13","key":"21606_CR45","doi-asserted-by":"publisher","first-page":"3435","DOI":"10.1016\/j.biomaterials.2011.01.021","volume":"32","author":"K Xiao","year":"2011","unstructured":"Xiao, K. et al. The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles. Biomaterials 32 (13), 3435\u20133446. https:\/\/doi.org\/10.1016\/j.biomaterials.2011.01.021 (2011).","journal-title":"Biomaterials"},{"issue":"3","key":"21606_CR46","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.partic.2010.01.003","volume":"8","author":"R Tantra","year":"2010","unstructured":"Tantra, R., Schulze, P. & Quincey, P. Effect of nanoparticle concentration on zeta-potential measurement results and reproducibility. Particuology 8 (3), 279\u2013285 (2010).","journal-title":"Particuology"},{"key":"21606_CR47","doi-asserted-by":"publisher","first-page":"105511","DOI":"10.1016\/j.jtice.2024.105511","volume":"161","author":"MK Secario","year":"2024","unstructured":"Secario, M. K., Truong, T. T. V., Chen, C. C., Lai, J. Y. & Lue, S. J. Size-dependent antibacterial efficacy of silver nanoparticles from a green synthesis method: effects of extract quantity and origin. J. Taiwan Inst. Chem. Eng. 161, 105511. https:\/\/doi.org\/10.1016\/j.jtice.2024.105511 (2024).","journal-title":"J. Taiwan Inst. Chem. Eng."},{"issue":"7","key":"21606_CR48","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3390\/jfb15070195","volume":"15","author":"I El-Habib","year":"2024","unstructured":"El-Habib, I. et al. Antibacterial size effect of ZnO nanoparticles and their role as additives in emulsion waterborne paint. J. Funct. Biomater. 15 (7), 195. https:\/\/doi.org\/10.3390\/jfb15070195 (2024). Published 2024 Jul 17.","journal-title":"J. Funct. Biomater."},{"issue":"1","key":"21606_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2004.01.044","volume":"278","author":"VR Sinha","year":"2004","unstructured":"Sinha, V. R., Bansal, K., Kaushik, R., Kumria, R. & Trehan, A. Poly-epsilon-caprolactone microspheres and nanospheres: an overview. Int. J. Pharm. 278 (1), 1\u201323. https:\/\/doi.org\/10.1016\/j.ijpharm.2004.01.044 (2004).","journal-title":"Int. J. Pharm."},{"key":"21606_CR50","doi-asserted-by":"publisher","DOI":"10.1007\/s00289-025-05842-z","author":"R Kadkhodaei","year":"2025","unstructured":"Kadkhodaei, R. et al. Fabrication of biodegradable polycaprolactone\/chitosan nanoparticle\/sodium alginate-based tablet implants for controlled doxorubicin release. Polym. Bull. https:\/\/doi.org\/10.1007\/s00289-025-05842-z (2025).","journal-title":"Polym. Bull."},{"key":"21606_CR51","doi-asserted-by":"publisher","unstructured":"Lee, C. H., Li, Y. J., Huang, C. C. & Lai, J. Y. Poly(\u03b5-caprolactone) nanocapsule carriers with sustained drug release: single dose for long-term glaucoma treatment. Nanoscale 9(32):11754\u201311764. https:\/\/doi.org\/10.1039\/c7nr03221h","DOI":"10.1039\/c7nr03221h"},{"key":"21606_CR52","doi-asserted-by":"publisher","unstructured":"Chai, F. et al. Doxorubicin-loaded poly (lactic-co-glycolic acid) nanoparticles coated with chitosan\/alginate by layer by layer technology for antitumor applications. Int J Nanomedicine. ;12:1791\u20131802. doi:10.2147\/IJN. S130404. Erratum in: Int J Nanomedicine. 2021;16:4187. (2017). https:\/\/doi.org\/10.2147\/IJN. S322673. PMID: 28424550; PMCID: PMC5344431.","DOI":"10.2147\/IJN"},{"key":"21606_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/polym11020304","author":"B Lu","year":"2019","unstructured":"Lu, B., Lv, X., Le, Y. & Chitosan-Modified, P. L. G. A. Nanoparticles for Control-Released Drug Delivery. Polym. (Basel) ;11(2):304. doi:https:\/\/doi.org\/10.3390\/polym11020304. (2019). PMID: 30960288; PMCID: PMC6419218."},{"key":"21606_CR54","unstructured":"Kamath, M., Ahmed, S., Dhanasekaran, M. & Winkins, S. Polycaprolactone scaffold engineered for sustained release of resveratrol: therapeutic enhancement in bone tissue engineering. Int. J. Nanomed. 9(1):183\u2013195"},{"key":"21606_CR55","doi-asserted-by":"publisher","first-page":"125186","DOI":"10.1016\/j.colsurfa.2020.125186","volume":"603","author":"N Pan","year":"2020","unstructured":"Pan, N. et al. Antibacterial Poly (\u03b5-caprolactone) fibrous membranes filled with reduced graphene oxide-silver. Colloids Surf., A. 603, 125186. https:\/\/doi.org\/10.1016\/j.colsurfa.2020.125186 (2020).","journal-title":"Colloids Surf., A"},{"issue":"8","key":"21606_CR56","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1007\/s12010-015-1709-9","volume":"176","author":"R Thomas","year":"2015","unstructured":"Thomas, R., Soumya, K. R., Mathew, J. & Radhakrishnan, E. K. Electrospun Polycaprolactone membrane incorporated with biosynthesized silver nanoparticles as effective wound dressing material. Appl. Biochem. Biotechnol. 176 (8), 2213\u20132224. https:\/\/doi.org\/10.1007\/s12010-015-1709-9 (2015).","journal-title":"Appl. Biochem. Biotechnol."},{"issue":"1","key":"21606_CR57","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12951-017-0262-9","volume":"15","author":"MI Shaaban","year":"2017","unstructured":"Shaaban, M. I., Shaker, M. A. & Mady, F. M. Imipenem\/cilastatin encapsulated polymeric nanoparticles for destroying carbapenem-resistant bacterial isolates. J. Nanobiotechnol. 15 (1), 29. https:\/\/doi.org\/10.1186\/s12951-017-0262-9 (2017). Published 2017 Apr 11.","journal-title":"J. Nanobiotechnol."},{"key":"21606_CR58","doi-asserted-by":"publisher","first-page":"871097","DOI":"10.1155\/2013\/871097","volume":"2013","author":"AJ Kora","year":"2013","unstructured":"Kora, A. J. & Rastogi, L. Enhancement of antibacterial activity of capped silver nanoparticles in combination with antibiotics, on model gram-negative and gram-positive bacteria. Bioinorg. Chem. Appl. 2013, 871097. https:\/\/doi.org\/10.1155\/2013\/871097 (2013). PMID: 23970844; PMCID: PMC3732601.","journal-title":"Bioinorg. Chem. Appl."},{"key":"21606_CR59","doi-asserted-by":"publisher","unstructured":"Mohamed, A. A. et al. A combined therapy of meropenem-ZnO nanoparticles efficiently eliminates carbapenem-resistant Klebsiella pneumoniae biofilms, with reduced nephrotoxicity (in vitro). Lett. Appl. Microbiol. 77(12):ovae136. https:\/\/doi.org\/10.1093\/lambio\/ovae136","DOI":"10.1093\/lambio\/ovae136"},{"key":"21606_CR60","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.addr.2014.10.027","volume":"78","author":"BD Brooks","year":"2014","unstructured":"Brooks, B. D. & Brooks, A. E. Therapeutic strategies to combat antibiotic resistance. Adv. Drug Deliv Rev. 78, 14\u201327. https:\/\/doi.org\/10.1016\/j.addr.2014.10.027 (2014).","journal-title":"Adv. Drug Deliv Rev."},{"key":"21606_CR61","doi-asserted-by":"publisher","first-page":"109741","DOI":"10.1016\/j.msec.2019.109741","volume":"103","author":"N Hasan","year":"2019","unstructured":"Hasan, N. et al. PEI\/NONOates-doped PLGA nanoparticles for eradicating methicillin-resistant Staphylococcus aureus biofilm in diabetic wounds via binding to the biofilm matrix. Mater. Sci. Eng. C Mater. Biol. Appl. 103, 109741. https:\/\/doi.org\/10.1016\/j.msec.2019.109741 (2019).","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"21606_CR62","unstructured":"Zhang, R. et al. Multi pH-sensitive polymer\u2013drug conjugate mixed micelles for efficient co-delivery of doxorubicin and curcumin to synergistically suppress tumor metastasis. Biomaterials, 250, 120057. (2020). https:\/\/doi.org\/10. 1016\/j. biomaterials. 2020. 120057."},{"key":"21606_CR63","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1007\/s12221-024-00548-x","volume":"25","author":"YE Bulbul","year":"2024","unstructured":"Bulbul, Y. E. & Dilsiz, N. Polycaprolactone-Based composite electrospun nanofibers as hybrid biomaterial systems containing Hydroxyl- or carboxylic Acid-Functionalized multiwall carbon nanotubes. Fibers Polym. 25, 1701\u20131712. https:\/\/doi.org\/10.1007\/s12221-024-00548-x (2024).","journal-title":"Fibers Polym."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21606-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21606-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21606-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:06:45Z","timestamp":1761664005000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-21606-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["21606"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-21606-1","relation":{"references":[{"id-type":"doi","id":"10.3390\/polym11020304","asserted-by":"subject"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"assertion":[{"value":"12 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethical Approval was given, by Committee Director, Islamic Azad university, North Tehran Branch, and the relevant Judgment\u2019s reference number IR.IAU.TNB.REC.1403.133.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"37708"}}